Nicholas Lydon

Nicholas Lydon
Nicholas Lydon

Institutions Amgen
Alma mater University of Leeds, University of Dundee
Known for Gleevec
Notable awards Lasker Clinical Award (2009)

Nicholas B. Lydon is a British scientist and entrepreneur. He won 2009 Lasker Clinical Award for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukemia (CML).[1]

Lydon earned a BS in biochemistry from the University of Leeds, England and received his Ph.D in biochemistry from the University of Dundee, Scotland.

References